Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Liver Cirrhosis
Interventions
DRUG

Midodrine

• Midodrine starting at 0.25mg/kg/day in divided doses, increased to 0.5mg/kg/day after 7 days if MAP does not increase by \>10%

BIOLOGICAL

albumin

• Albumin infusion 1g/kg/day (max 20g) every two weeks (if pre-infusion serum albumin is \< 3.5 gm/dl

OTHER

Standard Medical Treatment

Standard Medical Treatment

Trial Locations (1)

110 070

RECRUITING

Institute of Liver & Biliary Sciences (ILBS), New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER